Correlation Between Seres Therapeutics and Janux Therapeutics
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Janux Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Janux Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Janux Therapeutics, you can compare the effects of market volatilities on Seres Therapeutics and Janux Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Janux Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Janux Therapeutics.
Diversification Opportunities for Seres Therapeutics and Janux Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Seres and Janux is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Janux Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Janux Therapeutics and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Janux Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Janux Therapeutics has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Janux Therapeutics go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Janux Therapeutics
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 2.93 times more return on investment than Janux Therapeutics. However, Seres Therapeutics is 2.93 times more volatile than Janux Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Janux Therapeutics is currently generating about -0.16 per unit of risk. If you would invest 70.00 in Seres Therapeutics on August 28, 2024 and sell it today you would earn a total of 18.00 from holding Seres Therapeutics or generate 25.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Janux Therapeutics
Performance |
| Timeline |
| Seres Therapeutics |
| Janux Therapeutics |
Seres Therapeutics and Janux Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Janux Therapeutics
The main advantage of trading using opposite Seres Therapeutics and Janux Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Janux Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Janux Therapeutics will offset losses from the drop in Janux Therapeutics' long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| Janux Therapeutics vs. Eliem Therapeutics | Janux Therapeutics vs. Scpharmaceuticals | Janux Therapeutics vs. Milestone Pharmaceuticals | Janux Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |